News Focus
News Focus
icon url

Tuff-Stuff

09/27/10 2:41 PM

#337177 RE: Tuff-Stuff #337176

Hospira (HSP +3.7%) shares surge on a report that a U.S. district court invalidated Sanofi-Aventis' (SNY -2.1%) patent on Taxotere, potentially opening the door for its generic version of the cancer treatment.